Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative everolimus in metastatic renal cell cancer
ISRCTN22979604Phase 2Completed
- Sponsor
- Royal Marsden NHS Foundation Trust
- Start
- Jan 2010
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of everolimus in renal cell carcinoma (RCC), sponsored by Royal Marsden NHS Foundation Trust. Primary endpoint: Safety of pre-operative and post-operative everolimus therapy. Started Jan 2010; status: completed.
02
Drugs
everolimus
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on ISRCTN22979604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN22979604.